Apr. 23, 2018News & Opinions
UK biotech Orchard Therapeutics has acquired GlaxoSmithKline’s (GSK) portfolio of approved and investigational rare disease gene therapies. The deal will see GSK take a 19.9% equity stake in Orchard Therapeutics along with a seat on ...
Apr. 19, 2018News & Opinions
European drugmakers GlaxoSmithKline of the UK and Novartis of Switzerland have agreed to contribute to a nearly $4 billion global research effort to fight drug-resistant strains of malaria.
Mar. 28, 2018News & Opinions
In a move that may explain why GlaxoSmithKline last week turned thumbs down on bidding for Pfizer’s consumer drugs business, the UK’s largest drugmaker has announced plans to buy Novartis’ 35.6% stake in the ...
Mar. 23, 2018News & Opinions
Britain’s largest pharmaceutical producer GlaxoSmithKline (GSK) has estimated that its costs related to Brexit, the country’s leaving the EU, could run as high as £70 million over the next two to three years.
Mar. 12, 2018News & Opinions
GlaxoSmithKline has been fined $55 milllion (£37.6 million) in its appeal of a pay-for-delay case dating back to the early 2000s and involving its now off-patent antidepressant Seroxat/Paxil.
Feb. 06, 2018News & Opinions
Pharmaceutical companies’ interest in buying consumer health businesses is waning, with more players interested in shedding the activities than acquiring them, reports suggest.
Jan. 18, 2018News & Opinions
GlaxoSmithKline (GSK), the UK’s largest drugmaker in terms of sales, is rumored to be preparing a bid for compatriot Vectura, an inhaled airways disease-focused player. The two companies already collaborate on respiratory therapies.
Jan. 12, 2018News & Opinions
A management reshuffle at the UK’s largest drugmaker, GlaxoSmithKline has caught the market’s attention, especially as it was carried through by closely watched CEO Emma Walmsley, who took over from Andrew Witty in spring 2017 ...
Jan. 03, 2018News & Opinions
UK drugmaker GlaxoSmithKline (GSK) has expanded its stake in its Saudi subsidiary Glaxo Saudi Arabia Limited (GSAL) by 26% to 75%.
Dec. 05, 2017News & Opinions
As a UK Parliament-select committee prepared for a public evidence session on Dec. 5, examining scenarios for trading arrangements with the UK post-Brexit, reports were circulating that investments worth “billions of pounds” ...
The latest information directly via newsletter.